Companies

See how salaries can vary from company to company

Unique Fabricating, Inc. engineers and manufactures multi-material foam, rubber, and plastic components utilized in noise, vibration, harshness, acoustical management, water and air sealing, decorative, and other functional applications. It offers die cut products, such as trim insulation, headliner insulation, fender acoustical pad, A/B/C pillar cover, dashboard seal, cup holder base, and under hood insulation products, as well as heating, ventilation, and air conditioning (HVAC) seals; thermoformed and compression molded products, including HVAC air ducts, door water shields, evaporator line... view company details

view company details

Arena Pharmaceuticals, Inc., a biopharmaceutical company, focuses on providing novel medicines with pharmacology and pharmacokinetics to patients worldwide. Its investigational clinical programs include ralinepag (APD811), which is in Phase III trial to treat pulmonary arterial hypertension; etrasimod (APD334) for ulcerative colitis, and Crohn's disease, as well as for atopic dermatitis and other indications; and Olorinab (APD371), which is in Phase II trial for the treatment of gastrointestinal pain. It is also developing APD418, a calcium-independent myofilament derepressor for the treatment... view company details

Red Bull is an energy drink sold by Red Bull GmbH, an Austrian company created in 1987. Red Bull has the highest market share of any energy drink in the world, with 6.790 billion cans sold in a year (as of 2018). Austrian entrepreneur Dietrich Mateschitz was inspired by an existing energy drink named Krating Daeng, which was first introduced and sold in Thailand by Chaleo Yoovidhya. He took this idea, modified the ingredients to suit the tastes of Westerners, and, in partnership with Chaleo, founded Red Bull GmbH in 1987 in Chakkapong, Thailand. In Thai, daeng means red, and a krating (known ... view company details

Anton Paar GmbH, founded in 1922 as a one-man locksmith‘s workshop, today is a globally active high-tech company headquartered in Graz, Austria with 29 sales and service subsidiaries worldwide. The company currently counts 2900 employees. Anton Paar develops and produces high-precision laboratory instruments as well as process measurement technology and provides custom-tailored automation and robotics solutions. A love of research and high quality standards have made Anton Paar a world market leader in the fields of density measurement, the determination of dissolved CO2, rheometry, material c... view company details

Expertly Balancing Experience and Innovation to Deliver Unique Solutions to Public and Private Clients. view company details

Esperion Therapeutics, Inc., a lipid management company, focuses on developing and commercializing oral therapies for the treatment of patients with elevated low density lipoprotein cholesterol (LDL-C). Its lead product candidate is bempedoic acid/ezetimibe combination tablet, a non-statin, orally available, LDL-C lowering therapy for patients with hypercholesterolemia and with atherosclerotic cardiovascular disease, and/or heterozygous familial hypercholesterolemia that is in Phase III long-term safety and tolerability study. The company has a license and collaboration agreement with Daiichi ... view company details

Aldi (stylised as ALDI) is the common brand of two German family owned discount supermarket chains with over 10,000 stores in 20 countries, and an estimated combined turnover of more than €50 billion. Based in Germany, the chain was founded by brothers Karl and Theo Albrecht in 1946 when they took over their mother's store in Essen, which had been in operation since 1913. The business was split into two separate groups in 1960, that later became Aldi Nord, headquartered in Essen, and Aldi Süd, headquartered in Mülheim. In 1962, they introduced the name Aldi (a syllabic abbreviation for Albrech... view company details

Aldi (stylised as ALDI) is the common brand of two German family owned discount supermarket chains with over 10,000 stores in 20 countries, and an estimated combined turnover of more than €50 billion. Based in Germany, the chain was founded by brothers Karl and Theo Albrecht in 1946 when they took over their mother's store in Essen, which had been in operation since 1913. The business was split into two separate groups in 1960, that later became Aldi Nord, headquartered in Essen, and Aldi Süd, headquartered in Mülheim. In 1962, they introduced the name Aldi (a syllabic abbreviation for Albrech... view company details

Dicerna Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery and development of ribonucleic acid interference (RNAi)-based pharmaceuticals. The company develops pharmaceuticals using its GalXC RNAi platform for the treatment of diseases involving the liver, including rare diseases, viral infectious diseases, chronic liver diseases, and cardiovascular diseases. Its principal development programs include DCR-PHXC for the treatment of primary hyperoxaluria; DCR-HBVS for the treatment of chronic hepatitis B virus infection; and a program for an undisclosed rare liver diseas... view company details

Coherus BioSciences, Inc., a commercial-stage biotherapeutics company, focuses on the biosimilar market worldwide. It markets UDENYCA, a long-acting granulocyte-colony stimulating factor, which stimulates production of granulocytes in order to promote the body's ability to fight infections. The company sells UDENYCA in the United States. Its clinical-stage product candidates include immunology, anti-tumor necrosis factor biosimilar candidates, CHS-1420 for adalimumab and CHS-0214 for etanercept, which has completed Phase III clinical programs; ophthalmology biosimilar candidates, CHS-3351 for ... view company details

Cellectar Biosciences, Inc., a clinical stage biopharmaceutical company, focuses on the discovery, development, and commercialization of drugs for the treatment of cancer. Its lead phospholipid drug conjugate (PDC) candidate is CLR 131, which is in Phase II clinical study in patients with relapsed or refractory (R/R) multiple myeloma (MM) and a range of B-cell malignancies, as well as in Phase I clinical study for R/R MM. The company also develops CLR 1900, a PDC chemotherapeutic program that is targeted to treat solid tumors. It has collaborative PDC programs with Pierre Fabre to develop CLR ... view company details

Siffrin empowers people with disabilities by encouraging self-advocacy. Siffrin services are individualized to meet the unique needs and desires of each person served. The purpose of each program is to support people in fully enjoying their community. view company details

Urban industrial style pizzeria featuring Neapolitan style pizza and craft beer from all over the country. Artisan cocktails and an eclectic wine list accentuate our unique vibe and incredible views. view company details

Providing products to marijuana enthusiasts around the world. Founded in 2003, our products are now available in over 1000 smoke shops globally. We specialize in glass storage jars, optics, glass cleaners and many other unique products. We're dedicated to ending cannabis prohibition and support the MPP. view company details

Ardmore Roderick has become one of the largest minority-owned engineering firms in the Midwest and one of the top 20 largest engineering firms headquartered in Illinois. We offer a unique set of services and varying areas of expertise, creating a well-rounded expert staff, resources and capabilities. view company details

Lapels has pioneered a unique Dry Cleaning Program that features a boutique like, Environmentally Friendly Dry Cleaning Experience. Lapels has been heralded as The Future of Dry Cleaning since 1999 when they started building a different kind of Dry Cleaning operation. view company details

Denali Therapeutics Inc., a biopharmaceutical company, discovers and develops therapeutic candidates for neurodegenerative diseases in the United States. The company offers leucine-rich repeat kinase 2 (LRRK2) inhibitor product candidates, including DNL201 and DNL151, which are in Phase 1 clinical trials for Parkinson's disease. It is also developing receptor interacting serine/threonine protein kinase 1 (RIPK1) product candidates, such as DNL747, a selective and brain-penetrant small molecule RIPK1 inhibitor product candidate that is in Phase 1b clinical trial for Alzheimer's disease and amyo... view company details

Epizyme, Inc., a late-stage biopharmaceutical company, discovers, develops, and commercializes novel epigenetic medicines for patients with cancer and other diseases primarily in the United States. The company's lead products candidate is tazemetostat, an inhibitor of the EZH2 histone methyltransferase, which is in the Phase II clinical trial for patients with relapsed or refractory non-hodgkin lymphoma (NHL); Phase II clinical trial for relapsed or refractory patients with mesothelioma characterized by BAP1 loss-of-function; and Phase II clinical trial for adults and Phase I clinical trial fo... view company details

Halozyme Therapeutics, Inc., a biotechnology company, engages in researching, developing, and commercializing novel oncology therapies in the United States, Switzerland, and internationally. Its human enzymes are used to facilitate the delivery of injected drugs and fluids, enhancing the efficacy and the convenience of other drugs or can be used to alter tissue structures for clinical benefit. The company's products are based on the Enhanze technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable biologics, such as monoclonal ... view company details